Last updated on August 2019

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers


Brief description of study

The primary objective of this study is to describe the safety profile of MenACYW conjugate vaccine and MENVEO when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers

Detailed Study Description

Approximately 16 months, which includes a safety follow-up contact at 6 months after the final vaccination

Clinical Study Identifier: NCT03673462

Find a site near you

Start Over

Investigational Site Number 8400076

Colorado Springs, CO United States
  Connect »

Investigational Site Number 8400063

Loxahatchee Groves, FL United States
  Connect »

Investigational Site Number 8400021

Winston-Salem, NC United States
  Connect »

Investigational Site Number 8400058

Corpus Christi, TX United States
  Connect »

Investigational Site Number 8400053

Salt Lake City, UT United States
  Connect »

Investigational Site Number 8400036

Salt Lake City, UT United States
  Connect »

Investigational Site Number 8400019

Salt Lake City, UT United States
  Connect »

Investigational Site Number 8400077

Charlottesville, VA United States
  Connect »